JP Morgan Raises Colgate-Palmolive (CL) Price Target to $104
Key Points
- JP Morgan reiterated an Overweight rating on Colgate-Palmolive Company and raised its price target from $103.00 to $104.00 on October 19, 2026.
- JP Morgan's $104 price target implies 11.35% upside from Colgate-Palmolive Company's ($CL) current $93.40 share price.
- Colgate-Palmolive shares recently traded around $93.40, sitting above their 50-day and 200-day moving averages as investors look ahead to upcoming earnings.
- Wall Street sentiment leans toward a buy recommendation, backed by a mean analyst price target of $98.10 across twenty analysts.
Get Colgate-Palmolive Company text alerts
We text you when insiders, Congress, analysts or big funds move on $CL.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Colgate-Palmolive Company alert may contain errors. Disclosures
On October 19, 2026, JP Morgan maintained its Overweight rating on Colgate-Palmolive Company (NYSE: CL) while lifting its price target to $104.00 from $103.00. The research note reflects the firm's forward-looking view on the consumer products maker as shares trade near the middle of their 52-week range.
CL
Colgate-Palmolive Company
JP Morgan vs. the S&P 500
Hypothetical returns from JP Morgan's disclosed trades, not real profit or advice. How we model this.
JP Morgan's Call on Colgate-Palmolive
In its research note published on October 19, 2026, JP Morgan kept an Overweight rating on the stock and nudged its target up by one dollar to $104.00. The adjustment follows earlier analyst activity on the stock over the prior couple of months, including updates from UBS, RBC Capital, Piper Sandler, and Wells Fargo leading up to the fall.
Other Institutional Activity in Colgate-Palmolive
Institutional investors have also adjusted their large holdings in the consumer defensive company. Bank Of New York Mellon Corporation grew its holdings by 1,010,517 shares, ending with 13,532,417 shares worth about $1,263,792,415. At the same time, Deutsche Bank AG reduced its position by 176,542 shares, leaving it with 11,751,973 shares valued at approximately $1,097,516,751.
Colgate-Palmolive Company Stock Up 0.7%
Colgate-Palmolive shares recently traded around $93.40 on October 19, 2026, close to the stock's closing price of $93.39 on that same day. The recent price sits about 4.8% above its 50-day moving average of $89.13 and about 5.0% above its 200-day moving average of $88.92. The stock has traded between a 52-week low of $74.55 and a 52-week high of $99.33.
$CL price target
Colgate-Palmolive Company daily closes and this analyst's $104 target. Not advice.
Recent Earnings
For the trailing twelve months, Colgate-Palmolive generated $21.05 billion in revenue and reported earnings of $2.54 per share. The company posted a net profit margin of 9.7% and a return on equity of 267.4%. Investors are awaiting the next corporate earnings update scheduled for October 30, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
4 analysts raised price targets.
-
EPS & revenue
EPS met estimates. Revenue missed estimates by 0.9%.
-
Profit surprise
EBITDA missed by 15 percent. Operating income missed by 17 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
4 target raises.
-
Earnings quality
Positive free cash flow.
Earnings Call Summary
Colgate delivered a solid first quarter with accelerating volume growth, especially in emerging markets and the Hill's pet food business, which grew nearly 5 percent. However, North America oral care remains weak and the company faces significant pressure from rising costs in resins, petrochemicals, and oils, which are expected to be up more than 20 percent year over year. Management is confident in its ability to maintain earnings growth through pricing, innovation, and efficiency programs while continuing to invest in brands.
Guidance The company reaffirmed full year earnings growth in the low to mid single digits. They expect gross margins to decline due to about $300 million in additional raw material and logistics costs tied to oil prices around $110 per barrel. They plan to offset inflation through revenue growth management, innovation, and a $200 million to $300 million cost savings program.
Fine but not compelling. Acceptable results that likely do not create a meaningful forward reset.
Dividend
Colgate-Palmolive currently pays an annualized dividend that yields 2.29%, supported by a payout ratio of 82.3%.
Insider Buying and Selling at Colgate-Palmolive Company
Company insiders have transacted shares over recent months ahead of the autumn updates. Chief Executive Officer Noel R. Wallace disposed of 322,042 shares valued at roughly $29.7 million on August 5, 2026. Additional sales included 4,170 shares by Director John T. Cahill on August 6, 2026, for about $389,358, and 10,000 shares by Officer Panagiotis Tsourapas on August 24, 2026, for approximately $920,477.
Analysts Set New Price Targets
Wall Street coverage includes a mix of ratings and targets. UBS maintained a Buy rating and a $109.00 target on August 3, 2026. RBC Capital reiterated an Outperform rating with a $104.00 target on September 8, 2026. Piper Sandler kept an Overweight rating while lowering its target from $98.00 to $95.00 on September 21, 2026. Wells Fargo maintained an Equal-Weight rating and lowered its target from $95.00 to $90.00 on October 5, 2026. Across twenty analyst opinions, the stock carries a consensus buy recommendation with a mean target price of $98.10.
About Colgate-Palmolive
Colgate-Palmolive Company manufactures and sells everyday consumer goods globally. The company operates through two main business segments: Oral, Personal and Home Care; and Pet Nutrition, producing well-known household brands used by millions daily.
Bottom Line
JP Morgan's updated target highlights steady confidence from major firms as the company approaches its next earnings announcement on October 30, 2026. Market participants will watch whether upcoming financial results validate the broader analyst consensus.
Related Filing Alerts
Source: JP Morgan's rating change on $CL (Oct 19, 2026). Written by software, not financial advice. How we make alerts